Literature DB >> 25550791

Increased frequencies of nuocytes in peripheral blood from patients with Graves' hyperthyroidism.

Xiaoyun Ji1, Qingli Bie1, Yingzhao Liu2, Jianguo Chen2, Zhaoliang Su1, Yumin Wu1, Xinyu Ying1, Huijian Yang1, Shengjun Wang1, Huaxi Xu1.   

Abstract

Newly identified nuocytes play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma and chronic rhinosinusitis. However, the contributions of nuocytes in the occurrence and development of Graves' hyperthyroidism remains unknown. Previous studies found that there was a predominant Th2 phenotype in patients with Graves' hyperthyroidism, it might relate to polarization of nuocytes. Nuocytes were defined by transcription factor RORα, various cell surface markers (T1/ST2, IL-17RB, ICOS, CD45) and associated cytokines. In this study, these cells related genes or molecules in PBMC from patients with Graves' hyperthyroidism were measured, and the potential correlation between them was analyzed. The expression levels of T1/ST2, IL-17RB, ICOS, IL-5 and IL-13, which represented nuocytes associated molecules were significantly increased in patients, meanwhile, the RORα mRNA also had a tendency to increase. In addition, IFN-γ and T-bet (Th1 related cytokine and transcription factor) were obviously decreased, and there was a positive correlation between IL-17RB and IL-13. These results suggested that there were polarized nuocytes in Graves' hyperthyroidism patients, and which closely related to the down-regulation of Th1 cells or relatively advantage of Th2 differentiation.

Entities:  

Keywords:  Graves’ hyperthyroidism; Nuocytes; cytokines; transcription factors

Mesh:

Substances:

Year:  2014        PMID: 25550791      PMCID: PMC4270543     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Authors:  April E Price; Hong-Erh Liang; Brandon M Sullivan; R Lee Reinhardt; Chris J Eisley; David J Erle; Richard M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 2.  Innate immune cell populations function as initiators and effectors in Th2 cytokine responses.

Authors:  Steven A Saenz; Mario Noti; David Artis
Journal:  Trends Immunol       Date:  2010-10-13       Impact factor: 16.687

Review 3.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 5.  Nuocytes and beyond: new insights into helminth expulsion.

Authors:  Daniel R Neill; Andrew N J McKenzie
Journal:  Trends Parasitol       Date:  2011-02-01

6.  Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells.

Authors:  Kazuyo Moro; Taketo Yamada; Masanobu Tanabe; Tsutomu Takeuchi; Tomokatsu Ikawa; Hiroshi Kawamoto; Jun-Ichi Furusawa; Masashi Ohtani; Hideki Fujii; Shigeo Koyasu
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

7.  The mutations of Th1 cell-specific T-box transcription factor may be associated with a predominant Th2 phenotype in gastric cancers.

Authors:  P Yang; G Qiu; S Wang; Z Su; J Chen; S Wang; F Kong; L Lu; T Ezaki; H Xu
Journal:  Int J Immunogenet       Date:  2010-02-19       Impact factor: 1.466

8.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

Review 9.  STAT3 in CD4+ T helper cell differentiation and inflammatory diseases.

Authors:  Charles E Egwuagu
Journal:  Cytokine       Date:  2009-08-03       Impact factor: 3.861

10.  Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.

Authors:  Xiaojin Liu; Mingcai Li; Yan Wu; Yanchun Zhou; Liangming Zeng; Tian Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-06-07       Impact factor: 3.575

View more
  1 in total

1.  IL-25 Promotes Th2 Immunity Responses in Asthmatic Mice via Nuocytes Activation.

Authors:  Chao Wang; Qingfa Liu; Fangfang Chen; Wenjuan Xu; Caiqing Zhang; Wei Xiao
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.